| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Abscess at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Kohl, Katrin S.
|
|
2007
|
25 |
31 |
p. 5821-5838
18 p.
|
article
|
| 2 |
Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
|
Rüggeberg, Jens U.
|
|
2007
|
25 |
31 |
p. 5675-5684
10 p.
|
article
|
| 3 |
Aseptic meningitis: Case definition and guidelines for collection, analysis and presentation of immunization safety data
|
Tapiainen, Terhi
|
|
2007
|
25 |
31 |
p. 5793-5802
10 p.
|
article
|
| 4 |
Cellulitis at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Halperin, Scott
|
|
2007
|
25 |
31 |
p. 5803-5820
18 p.
|
article
|
| 5 |
Eczema vaccinatum as an adverse event following exposure to vaccinia virus: Case definition & guidelines of data collection, analysis, and presentation of immunization safety data
|
Nell, Patricia
|
|
2007
|
25 |
31 |
p. 5725-5734
10 p.
|
article
|
| 6 |
Editorial Board
|
|
|
2007
|
25 |
31 |
p. CO2-
1 p.
|
article
|
| 7 |
Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2)
|
Voigt, Heiner
|
|
2007
|
25 |
31 |
p. 5915-5926
12 p.
|
article
|
| 8 |
Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): Case definitions and guidelines for collection, analysis, and presentation of immunization safety data
|
Sejvar, James J.
|
|
2007
|
25 |
31 |
p. 5771-5792
22 p.
|
article
|
| 9 |
Fatigue: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Jones, James F.
|
|
2007
|
25 |
31 |
p. 5685-5696
12 p.
|
article
|
| 10 |
Generalized vaccinia as an adverse event following exposure to vaccinia virus: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
|
Beigel, John
|
|
2007
|
25 |
31 |
p. 5745-5753
9 p.
|
article
|
| 11 |
Hepatitis B vaccination and first central nervous system demyelinating events: Reanalysis of a case–control study using the self-controlled case series method
|
Hocine, M.N.
|
|
2007
|
25 |
31 |
p. 5938-5943
6 p.
|
article
|
| 12 |
Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: Case definition and guidelines for data collection, analysis, and presentation
|
Buettcher, Michael
|
|
2007
|
25 |
31 |
p. 5875-5881
7 p.
|
article
|
| 13 |
Inadvertent inoculation as an adverse event following exposure to vaccinia virus: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
|
Wenger, Peter
|
|
2007
|
25 |
31 |
p. 5754-5762
9 p.
|
article
|
| 14 |
Induration at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Kohl, Katrin S.
|
|
2007
|
25 |
31 |
p. 5839-5857
19 p.
|
article
|
| 15 |
Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infection
|
Pancré, Véronique
|
|
2007
|
25 |
31 |
p. 5927-5937
11 p.
|
article
|
| 16 |
Progressive vaccinia as an adverse event following exposure to vaccinia virus: Case definition and guidelines of data collection, analysis, and presentation of immunization safety data
|
Nell, Patricia
|
|
2007
|
25 |
31 |
p. 5735-5744
10 p.
|
article
|
| 17 |
Rash including mucosal involvement: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Beigel, John
|
|
2007
|
25 |
31 |
p. 5697-5706
10 p.
|
article
|
| 18 |
Robust take following exposure to vaccinia virus: Case definition and guidelines of data collection, analysis, and presentation of immunization safety data
|
Graham, Philip L.
|
|
2007
|
25 |
31 |
p. 5763-5770
8 p.
|
article
|
| 19 |
Swelling at or near injection site: Case definition and guidelines for collection, analysis and presentation of immunization safety data
|
Kohl, Katrin S.
|
|
2007
|
25 |
31 |
p. 5858-5874
17 p.
|
article
|
| 20 |
The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection
|
Toubaji, Antoun
|
|
2007
|
25 |
31 |
p. 5882-5891
10 p.
|
article
|
| 21 |
The development of standardized case definitions and guidelines for adverse events following immunization
|
Kohl, Katrin S.
|
|
2007
|
25 |
31 |
p. 5671-5674
4 p.
|
article
|
| 22 |
The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition
|
Hijnen, Marcel
|
|
2007
|
25 |
31 |
p. 5902-5914
13 p.
|
article
|
| 23 |
Thrombocytopenia: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Wise, Robert P.
|
|
2007
|
25 |
31 |
p. 5717-5724
8 p.
|
article
|
| 24 |
Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
|
Jorch, Gerhard
|
|
2007
|
25 |
31 |
p. 5707-5716
10 p.
|
article
|
| 25 |
Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry
|
James, Cassandra M.
|
|
2007
|
25 |
31 |
p. 5892-5901
10 p.
|
article
|
Journal description